Global Aminoglycosides Antibiotics Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Aminoglycosides Antibiotics market size is predicted to grow from US$ 717 million in 2025 to US$ 666 million in 2031; it is expected to grow at a CAGR of -1.2% from 2025 to 2031.
Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.Aminoglycosides are potent bactericidal antibiotics that act by creating fissures in the outer membrane of the bacterial cell. They are particularly active against aerobic, gram-negative bacteria and act synergistically against certain gram-positive organisms.
The key players of Aminoglycosides Antibiotics include Jemicare, Teva, Novartis and Fangyuan-pharma. The top four manufacturers hold approximately 15% of the global market share,.
In terms of product type, Tobramycin is the largest segment, with a share of 34%. And in terms of application, Hospital has a share about 38 percent.
LP Information, Inc. (LPI) ' newest research report, the “Aminoglycosides Antibiotics Industry Forecast” looks at past sales and reviews total world Aminoglycosides Antibiotics sales in 2024, providing a comprehensive analysis by region and market sector of projected Aminoglycosides Antibiotics sales for 2025 through 2031. With Aminoglycosides Antibiotics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aminoglycosides Antibiotics industry.
This Insight Report provides a comprehensive analysis of the global Aminoglycosides Antibiotics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aminoglycosides Antibiotics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Aminoglycosides Antibiotics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aminoglycosides Antibiotics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aminoglycosides Antibiotics.
This report presents a comprehensive overview, market shares, and growth opportunities of Aminoglycosides Antibiotics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Aminoglycosides Antibiotics market?
What factors are driving Aminoglycosides Antibiotics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Aminoglycosides Antibiotics market opportunities vary by end market size?
How does Aminoglycosides Antibiotics break out by Type, by Application?
The global Aminoglycosides Antibiotics market size is predicted to grow from US$ 717 million in 2025 to US$ 666 million in 2031; it is expected to grow at a CAGR of -1.2% from 2025 to 2031.
Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.Aminoglycosides are potent bactericidal antibiotics that act by creating fissures in the outer membrane of the bacterial cell. They are particularly active against aerobic, gram-negative bacteria and act synergistically against certain gram-positive organisms.
The key players of Aminoglycosides Antibiotics include Jemicare, Teva, Novartis and Fangyuan-pharma. The top four manufacturers hold approximately 15% of the global market share,.
In terms of product type, Tobramycin is the largest segment, with a share of 34%. And in terms of application, Hospital has a share about 38 percent.
LP Information, Inc. (LPI) ' newest research report, the “Aminoglycosides Antibiotics Industry Forecast” looks at past sales and reviews total world Aminoglycosides Antibiotics sales in 2024, providing a comprehensive analysis by region and market sector of projected Aminoglycosides Antibiotics sales for 2025 through 2031. With Aminoglycosides Antibiotics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aminoglycosides Antibiotics industry.
This Insight Report provides a comprehensive analysis of the global Aminoglycosides Antibiotics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aminoglycosides Antibiotics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Aminoglycosides Antibiotics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aminoglycosides Antibiotics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aminoglycosides Antibiotics.
This report presents a comprehensive overview, market shares, and growth opportunities of Aminoglycosides Antibiotics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Tobramycin
- Gentamicin
- Amikacin
- Etimicin
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Jemicare
- Teva
- Novartis
- Fangyuan-pharma
- Aike Pharmaceutical
- Cipla
- Pfizer
- Fresenius Kabi
- Sun Pharma
- Hikma
- Lannett Company
What is the 10-year outlook for the global Aminoglycosides Antibiotics market?
What factors are driving Aminoglycosides Antibiotics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Aminoglycosides Antibiotics market opportunities vary by end market size?
How does Aminoglycosides Antibiotics break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Aminoglycosides Antibiotics Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Aminoglycosides Antibiotics by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Aminoglycosides Antibiotics by Country/Region, 2020, 2024 & 2031
2.2 Aminoglycosides Antibiotics Segment by Type
2.2.1 Tobramycin
2.2.2 Gentamicin
2.2.3 Amikacin
2.2.4 Etimicin
2.2.5 Others
2.3 Aminoglycosides Antibiotics Sales by Type
2.3.1 Global Aminoglycosides Antibiotics Sales Market Share by Type (2020-2025)
2.3.2 Global Aminoglycosides Antibiotics Revenue and Market Share by Type (2020-2025)
2.3.3 Global Aminoglycosides Antibiotics Sale Price by Type (2020-2025)
2.4 Aminoglycosides Antibiotics Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Aminoglycosides Antibiotics Sales by Application
2.5.1 Global Aminoglycosides Antibiotics Sale Market Share by Application (2020-2025)
2.5.2 Global Aminoglycosides Antibiotics Revenue and Market Share by Application (2020-2025)
2.5.3 Global Aminoglycosides Antibiotics Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Aminoglycosides Antibiotics Breakdown Data by Company
3.1.1 Global Aminoglycosides Antibiotics Annual Sales by Company (2020-2025)
3.1.2 Global Aminoglycosides Antibiotics Sales Market Share by Company (2020-2025)
3.2 Global Aminoglycosides Antibiotics Annual Revenue by Company (2020-2025)
3.2.1 Global Aminoglycosides Antibiotics Revenue by Company (2020-2025)
3.2.2 Global Aminoglycosides Antibiotics Revenue Market Share by Company (2020-2025)
3.3 Global Aminoglycosides Antibiotics Sale Price by Company
3.4 Key Manufacturers Aminoglycosides Antibiotics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aminoglycosides Antibiotics Product Location Distribution
3.4.2 Players Aminoglycosides Antibiotics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AMINOGLYCOSIDES ANTIBIOTICS BY GEOGRAPHIC REGION
4.1 World Historic Aminoglycosides Antibiotics Market Size by Geographic Region (2020-2025)
4.1.1 Global Aminoglycosides Antibiotics Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Aminoglycosides Antibiotics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Aminoglycosides Antibiotics Market Size by Country/Region (2020-2025)
4.2.1 Global Aminoglycosides Antibiotics Annual Sales by Country/Region (2020-2025)
4.2.2 Global Aminoglycosides Antibiotics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Aminoglycosides Antibiotics Sales Growth
4.4 APAC Aminoglycosides Antibiotics Sales Growth
4.5 Europe Aminoglycosides Antibiotics Sales Growth
4.6 Middle East & Africa Aminoglycosides Antibiotics Sales Growth
5 AMERICAS
5.1 Americas Aminoglycosides Antibiotics Sales by Country
5.1.1 Americas Aminoglycosides Antibiotics Sales by Country (2020-2025)
5.1.2 Americas Aminoglycosides Antibiotics Revenue by Country (2020-2025)
5.2 Americas Aminoglycosides Antibiotics Sales by Type (2020-2025)
5.3 Americas Aminoglycosides Antibiotics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Aminoglycosides Antibiotics Sales by Region
6.1.1 APAC Aminoglycosides Antibiotics Sales by Region (2020-2025)
6.1.2 APAC Aminoglycosides Antibiotics Revenue by Region (2020-2025)
6.2 APAC Aminoglycosides Antibiotics Sales by Type (2020-2025)
6.3 APAC Aminoglycosides Antibiotics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Aminoglycosides Antibiotics by Country
7.1.1 Europe Aminoglycosides Antibiotics Sales by Country (2020-2025)
7.1.2 Europe Aminoglycosides Antibiotics Revenue by Country (2020-2025)
7.2 Europe Aminoglycosides Antibiotics Sales by Type (2020-2025)
7.3 Europe Aminoglycosides Antibiotics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Aminoglycosides Antibiotics by Country
8.1.1 Middle East & Africa Aminoglycosides Antibiotics Sales by Country (2020-2025)
8.1.2 Middle East & Africa Aminoglycosides Antibiotics Revenue by Country (2020-2025)
8.2 Middle East & Africa Aminoglycosides Antibiotics Sales by Type (2020-2025)
8.3 Middle East & Africa Aminoglycosides Antibiotics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Aminoglycosides Antibiotics
10.3 Manufacturing Process Analysis of Aminoglycosides Antibiotics
10.4 Industry Chain Structure of Aminoglycosides Antibiotics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Aminoglycosides Antibiotics Distributors
11.3 Aminoglycosides Antibiotics Customer
12 WORLD FORECAST REVIEW FOR AMINOGLYCOSIDES ANTIBIOTICS BY GEOGRAPHIC REGION
12.1 Global Aminoglycosides Antibiotics Market Size Forecast by Region
12.1.1 Global Aminoglycosides Antibiotics Forecast by Region (2026-2031)
12.1.2 Global Aminoglycosides Antibiotics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Aminoglycosides Antibiotics Forecast by Type (2026-2031)
12.7 Global Aminoglycosides Antibiotics Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Jemicare
13.1.1 Jemicare Company Information
13.1.2 Jemicare Aminoglycosides Antibiotics Product Portfolios and Specifications
13.1.3 Jemicare Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Jemicare Main Business Overview
13.1.5 Jemicare Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Aminoglycosides Antibiotics Product Portfolios and Specifications
13.2.3 Teva Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Aminoglycosides Antibiotics Product Portfolios and Specifications
13.3.3 Novartis Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Fangyuan-pharma
13.4.1 Fangyuan-pharma Company Information
13.4.2 Fangyuan-pharma Aminoglycosides Antibiotics Product Portfolios and Specifications
13.4.3 Fangyuan-pharma Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Fangyuan-pharma Main Business Overview
13.4.5 Fangyuan-pharma Latest Developments
13.5 Aike Pharmaceutical
13.5.1 Aike Pharmaceutical Company Information
13.5.2 Aike Pharmaceutical Aminoglycosides Antibiotics Product Portfolios and Specifications
13.5.3 Aike Pharmaceutical Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Aike Pharmaceutical Main Business Overview
13.5.5 Aike Pharmaceutical Latest Developments
13.6 Cipla
13.6.1 Cipla Company Information
13.6.2 Cipla Aminoglycosides Antibiotics Product Portfolios and Specifications
13.6.3 Cipla Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Cipla Main Business Overview
13.6.5 Cipla Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Aminoglycosides Antibiotics Product Portfolios and Specifications
13.7.3 Pfizer Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Fresenius Kabi
13.8.1 Fresenius Kabi Company Information
13.8.2 Fresenius Kabi Aminoglycosides Antibiotics Product Portfolios and Specifications
13.8.3 Fresenius Kabi Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Fresenius Kabi Main Business Overview
13.8.5 Fresenius Kabi Latest Developments
13.9 Sun Pharma
13.9.1 Sun Pharma Company Information
13.9.2 Sun Pharma Aminoglycosides Antibiotics Product Portfolios and Specifications
13.9.3 Sun Pharma Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Sun Pharma Main Business Overview
13.9.5 Sun Pharma Latest Developments
13.10 Hikma
13.10.1 Hikma Company Information
13.10.2 Hikma Aminoglycosides Antibiotics Product Portfolios and Specifications
13.10.3 Hikma Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Hikma Main Business Overview
13.10.5 Hikma Latest Developments
13.11 Lannett Company
13.11.1 Lannett Company Company Information
13.11.2 Lannett Company Aminoglycosides Antibiotics Product Portfolios and Specifications
13.11.3 Lannett Company Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Lannett Company Main Business Overview
13.11.5 Lannett Company Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Aminoglycosides Antibiotics Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Aminoglycosides Antibiotics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTobramycin
Table 4. Major Players of Gentamicin
Table 5. Major Players of Amikacin
Table 6. Major Players of Etimicin
Table 7. Major Players of Others
Table 8. Global Aminoglycosides Antibiotics Sales byType (2020-2025) & (M Units)
Table 9. Global Aminoglycosides Antibiotics Sales Market Share byType (2020-2025)
Table 10. Global Aminoglycosides Antibiotics Revenue byType (2020-2025) & ($ million)
Table 11. Global Aminoglycosides Antibiotics Revenue Market Share byType (2020-2025)
Table 12. Global Aminoglycosides Antibiotics Sale Price byType (2020-2025) & (US$/Unit)
Table 13. Global Aminoglycosides Antibiotics Sale by Application (2020-2025) & (M Units)
Table 14. Global Aminoglycosides Antibiotics Sale Market Share by Application (2020-2025)
Table 15. Global Aminoglycosides Antibiotics Revenue by Application (2020-2025) & ($ million)
Table 16. Global Aminoglycosides Antibiotics Revenue Market Share by Application (2020-2025)
Table 17. Global Aminoglycosides Antibiotics Sale Price by Application (2020-2025) & (US$/Unit)
Table 18. Global Aminoglycosides Antibiotics Sales by Company (2020-2025) & (M Units)
Table 19. Global Aminoglycosides Antibiotics Sales Market Share by Company (2020-2025)
Table 20. Global Aminoglycosides Antibiotics Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Aminoglycosides Antibiotics Revenue Market Share by Company (2020-2025)
Table 22. Global Aminoglycosides Antibiotics Sale Price by Company (2020-2025) & (US$/Unit)
Table 23. Key Manufacturers Aminoglycosides Antibiotics Producing Area Distribution and Sales Area
Table 24. Players Aminoglycosides Antibiotics Products Offered
Table 25. Aminoglycosides Antibiotics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Aminoglycosides Antibiotics Sales by Geographic Region (2020-2025) & (M Units)
Table 29. Global Aminoglycosides Antibiotics Sales Market Share Geographic Region (2020-2025)
Table 30. Global Aminoglycosides Antibiotics Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Aminoglycosides Antibiotics Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Aminoglycosides Antibiotics Sales by Country/Region (2020-2025) & (M Units)
Table 33. Global Aminoglycosides Antibiotics Sales Market Share by Country/Region (2020-2025)
Table 34. Global Aminoglycosides Antibiotics Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Aminoglycosides Antibiotics Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Aminoglycosides Antibiotics Sales by Country (2020-2025) & (M Units)
Table 37. Americas Aminoglycosides Antibiotics Sales Market Share by Country (2020-2025)
Table 38. Americas Aminoglycosides Antibiotics Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Aminoglycosides Antibiotics Sales byType (2020-2025) & (M Units)
Table 40. Americas Aminoglycosides Antibiotics Sales by Application (2020-2025) & (M Units)
Table 41. APAC Aminoglycosides Antibiotics Sales by Region (2020-2025) & (M Units)
Table 42. APAC Aminoglycosides Antibiotics Sales Market Share by Region (2020-2025)
Table 43. APAC Aminoglycosides Antibiotics Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Aminoglycosides Antibiotics Sales byType (2020-2025) & (M Units)
Table 45. APAC Aminoglycosides Antibiotics Sales by Application (2020-2025) & (M Units)
Table 46. Europe Aminoglycosides Antibiotics Sales by Country (2020-2025) & (M Units)
Table 47. Europe Aminoglycosides Antibiotics Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Aminoglycosides Antibiotics Sales byType (2020-2025) & (M Units)
Table 49. Europe Aminoglycosides Antibiotics Sales by Application (2020-2025) & (M Units)
Table 50. Middle East & Africa Aminoglycosides Antibiotics Sales by Country (2020-2025) & (M Units)
Table 51. Middle East & Africa Aminoglycosides Antibiotics Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Aminoglycosides Antibiotics Sales byType (2020-2025) & (M Units)
Table 53. Middle East & Africa Aminoglycosides Antibiotics Sales by Application (2020-2025) & (M Units)
Table 54. Key Market Drivers & Growth Opportunities of Aminoglycosides Antibiotics
Table 55. Key Market Challenges & Risks of Aminoglycosides Antibiotics
Table 56. Key IndustryTrends of Aminoglycosides Antibiotics
Table 57. Aminoglycosides Antibiotics Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Aminoglycosides Antibiotics Distributors List
Table 60. Aminoglycosides Antibiotics Customer List
Table 61. Global Aminoglycosides Antibiotics SalesForecast by Region (2026-2031) & (M Units)
Table 62. Global Aminoglycosides Antibiotics RevenueForecast by Region (2026-2031) & ($ millions)
Table 63. Americas Aminoglycosides Antibiotics SalesForecast by Country (2026-2031) & (M Units)
Table 64. Americas Aminoglycosides Antibiotics Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 65. APAC Aminoglycosides Antibiotics SalesForecast by Region (2026-2031) & (M Units)
Table 66. APAC Aminoglycosides Antibiotics Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 67. Europe Aminoglycosides Antibiotics SalesForecast by Country (2026-2031) & (M Units)
Table 68. Europe Aminoglycosides Antibiotics RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Aminoglycosides Antibiotics SalesForecast by Country (2026-2031) & (M Units)
Table 70. Middle East & Africa Aminoglycosides Antibiotics RevenueForecast by Country (2026-2031) & ($ millions)
Table 71. Global Aminoglycosides Antibiotics SalesForecast byType (2026-2031) & (M Units)
Table 72. Global Aminoglycosides Antibiotics RevenueForecast byType (2026-2031) & ($ millions)
Table 73. Global Aminoglycosides Antibiotics SalesForecast by Application (2026-2031) & (M Units)
Table 74. Global Aminoglycosides Antibiotics RevenueForecast by Application (2026-2031) & ($ millions)
Table 75. Jemicare Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 76. Jemicare Aminoglycosides Antibiotics Product Portfolios and Specifications
Table 77. Jemicare Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Jemicare Main Business
Table 79. Jemicare Latest Developments
Table 80.Teva Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 81.Teva Aminoglycosides Antibiotics Product Portfolios and Specifications
Table 82.Teva Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83.Teva Main Business
Table 84.Teva Latest Developments
Table 85. Novartis Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 86. Novartis Aminoglycosides Antibiotics Product Portfolios and Specifications
Table 87. Novartis Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Novartis Main Business
Table 89. Novartis Latest Developments
Table 90.Fangyuan-pharma Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 91.Fangyuan-pharma Aminoglycosides Antibiotics Product Portfolios and Specifications
Table 92.Fangyuan-pharma Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93.Fangyuan-pharma Main Business
Table 94.Fangyuan-pharma Latest Developments
Table 95. Aike Pharmaceutical Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 96. Aike Pharmaceutical Aminoglycosides Antibiotics Product Portfolios and Specifications
Table 97. Aike Pharmaceutical Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Aike Pharmaceutical Main Business
Table 99. Aike Pharmaceutical Latest Developments
Table 100. Cipla Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 101. Cipla Aminoglycosides Antibiotics Product Portfolios and Specifications
Table 102. Cipla Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Cipla Main Business
Table 104. Cipla Latest Developments
Table 105. Pfizer Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 106. Pfizer Aminoglycosides Antibiotics Product Portfolios and Specifications
Table 107. Pfizer Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Pfizer Main Business
Table 109. Pfizer Latest Developments
Table 110.Fresenius Kabi Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 111.Fresenius Kabi Aminoglycosides Antibiotics Product Portfolios and Specifications
Table 112.Fresenius Kabi Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113.Fresenius Kabi Main Business
Table 114.Fresenius Kabi Latest Developments
Table 115. Sun Pharma Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 116. Sun Pharma Aminoglycosides Antibiotics Product Portfolios and Specifications
Table 117. Sun Pharma Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Sun Pharma Main Business
Table 119. Sun Pharma Latest Developments
Table 120. Hikma Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 121. Hikma Aminoglycosides Antibiotics Product Portfolios and Specifications
Table 122. Hikma Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Hikma Main Business
Table 124. Hikma Latest Developments
Table 125. Lannett Company Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 126. Lannett Company Aminoglycosides Antibiotics Product Portfolios and Specifications
Table 127. Lannett Company Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Lannett Company Main Business
Table 129. Lannett Company Latest Developments
LIST OFFIGURES
Figure 1. Picture of Aminoglycosides Antibiotics
Figure 2. Aminoglycosides Antibiotics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Aminoglycosides Antibiotics Sales Growth Rate 2020-2031 (M Units)
Figure 7. Global Aminoglycosides Antibiotics Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Aminoglycosides Antibiotics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Aminoglycosides Antibiotics Sales Market Share by Country/Region (2024)
Figure 10. Aminoglycosides Antibiotics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofTobramycin
Figure 12. Product Picture of Gentamicin
Figure 13. Product Picture of Amikacin
Figure 14. Product Picture of Etimicin
Figure 15. Product Picture of Others
Figure 16. Global Aminoglycosides Antibiotics Sales Market Share byType in 2025
Figure 17. Global Aminoglycosides Antibiotics Revenue Market Share byType (2020-2025)
Figure 18. Aminoglycosides Antibiotics Consumed in Hospital
Figure 19. Global Aminoglycosides Antibiotics Market: Hospital (2020-2025) & (M Units)
Figure 20. Aminoglycosides Antibiotics Consumed in Clinic
Figure 21. Global Aminoglycosides Antibiotics Market: Clinic (2020-2025) & (M Units)
Figure 22. Aminoglycosides Antibiotics Consumed in Others
Figure 23. Global Aminoglycosides Antibiotics Market: Others (2020-2025) & (M Units)
Figure 24. Global Aminoglycosides Antibiotics Sale Market Share by Application (2024)
Figure 25. Global Aminoglycosides Antibiotics Revenue Market Share by Application in 2025
Figure 26. Aminoglycosides Antibiotics Sales by Company in 2025 (M Units)
Figure 27. Global Aminoglycosides Antibiotics Sales Market Share by Company in 2025
Figure 28. Aminoglycosides Antibiotics Revenue by Company in 2025 ($ millions)
Figure 29. Global Aminoglycosides Antibiotics Revenue Market Share by Company in 2025
Figure 30. Global Aminoglycosides Antibiotics Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Aminoglycosides Antibiotics Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Aminoglycosides Antibiotics Sales 2020-2025 (M Units)
Figure 33. Americas Aminoglycosides Antibiotics Revenue 2020-2025 ($ millions)
Figure 34. APAC Aminoglycosides Antibiotics Sales 2020-2025 (M Units)
Figure 35. APAC Aminoglycosides Antibiotics Revenue 2020-2025 ($ millions)
Figure 36. Europe Aminoglycosides Antibiotics Sales 2020-2025 (M Units)
Figure 37. Europe Aminoglycosides Antibiotics Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Aminoglycosides Antibiotics Sales 2020-2025 (M Units)
Figure 39. Middle East & Africa Aminoglycosides Antibiotics Revenue 2020-2025 ($ millions)
Figure 40. Americas Aminoglycosides Antibiotics Sales Market Share by Country in 2025
Figure 41. Americas Aminoglycosides Antibiotics Revenue Market Share by Country (2020-2025)
Figure 42. Americas Aminoglycosides Antibiotics Sales Market Share byType (2020-2025)
Figure 43. Americas Aminoglycosides Antibiotics Sales Market Share by Application (2020-2025)
Figure 44. United States Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Aminoglycosides Antibiotics Sales Market Share by Region in 2025
Figure 49. APAC Aminoglycosides Antibiotics Revenue Market Share by Region (2020-2025)
Figure 50. APAC Aminoglycosides Antibiotics Sales Market Share byType (2020-2025)
Figure 51. APAC Aminoglycosides Antibiotics Sales Market Share by Application (2020-2025)
Figure 52. China Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 56. India Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 58. ChinaTaiwan Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Aminoglycosides Antibiotics Sales Market Share by Country in 2025
Figure 60. Europe Aminoglycosides Antibiotics Revenue Market Share by Country (2020-2025)
Figure 61. Europe Aminoglycosides Antibiotics Sales Market Share byType (2020-2025)
Figure 62. Europe Aminoglycosides Antibiotics Sales Market Share by Application (2020-2025)
Figure 63. Germany Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 64.France Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Aminoglycosides Antibiotics Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Aminoglycosides Antibiotics Sales Market Share byType (2020-2025)
Figure 70. Middle East & Africa Aminoglycosides Antibiotics Sales Market Share by Application (2020-2025)
Figure 71. Egypt Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 74.Turkey Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Aminoglycosides Antibiotics in 2025
Figure 77. Manufacturing Process Analysis of Aminoglycosides Antibiotics
Figure 78. Industry Chain Structure of Aminoglycosides Antibiotics
Figure 79. Channels of Distribution
Figure 80. Global Aminoglycosides Antibiotics Sales MarketForecast by Region (2026-2031)
Figure 81. Global Aminoglycosides Antibiotics Revenue Market ShareForecast by Region (2026-2031)
Figure 82. Global Aminoglycosides Antibiotics Sales Market ShareForecast byType (2026-2031)
Figure 83. Global Aminoglycosides Antibiotics Revenue Market ShareForecast byType (2026-2031)
Figure 84. Global Aminoglycosides Antibiotics Sales Market ShareForecast by Application (2026-2031)
Figure 85. Global Aminoglycosides Antibiotics Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Aminoglycosides Antibiotics Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Aminoglycosides Antibiotics by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Aminoglycosides Antibiotics by Country/Region, 2020, 2024 & 2031
2.2 Aminoglycosides Antibiotics Segment by Type
2.2.1 Tobramycin
2.2.2 Gentamicin
2.2.3 Amikacin
2.2.4 Etimicin
2.2.5 Others
2.3 Aminoglycosides Antibiotics Sales by Type
2.3.1 Global Aminoglycosides Antibiotics Sales Market Share by Type (2020-2025)
2.3.2 Global Aminoglycosides Antibiotics Revenue and Market Share by Type (2020-2025)
2.3.3 Global Aminoglycosides Antibiotics Sale Price by Type (2020-2025)
2.4 Aminoglycosides Antibiotics Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Aminoglycosides Antibiotics Sales by Application
2.5.1 Global Aminoglycosides Antibiotics Sale Market Share by Application (2020-2025)
2.5.2 Global Aminoglycosides Antibiotics Revenue and Market Share by Application (2020-2025)
2.5.3 Global Aminoglycosides Antibiotics Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Aminoglycosides Antibiotics Breakdown Data by Company
3.1.1 Global Aminoglycosides Antibiotics Annual Sales by Company (2020-2025)
3.1.2 Global Aminoglycosides Antibiotics Sales Market Share by Company (2020-2025)
3.2 Global Aminoglycosides Antibiotics Annual Revenue by Company (2020-2025)
3.2.1 Global Aminoglycosides Antibiotics Revenue by Company (2020-2025)
3.2.2 Global Aminoglycosides Antibiotics Revenue Market Share by Company (2020-2025)
3.3 Global Aminoglycosides Antibiotics Sale Price by Company
3.4 Key Manufacturers Aminoglycosides Antibiotics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aminoglycosides Antibiotics Product Location Distribution
3.4.2 Players Aminoglycosides Antibiotics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AMINOGLYCOSIDES ANTIBIOTICS BY GEOGRAPHIC REGION
4.1 World Historic Aminoglycosides Antibiotics Market Size by Geographic Region (2020-2025)
4.1.1 Global Aminoglycosides Antibiotics Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Aminoglycosides Antibiotics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Aminoglycosides Antibiotics Market Size by Country/Region (2020-2025)
4.2.1 Global Aminoglycosides Antibiotics Annual Sales by Country/Region (2020-2025)
4.2.2 Global Aminoglycosides Antibiotics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Aminoglycosides Antibiotics Sales Growth
4.4 APAC Aminoglycosides Antibiotics Sales Growth
4.5 Europe Aminoglycosides Antibiotics Sales Growth
4.6 Middle East & Africa Aminoglycosides Antibiotics Sales Growth
5 AMERICAS
5.1 Americas Aminoglycosides Antibiotics Sales by Country
5.1.1 Americas Aminoglycosides Antibiotics Sales by Country (2020-2025)
5.1.2 Americas Aminoglycosides Antibiotics Revenue by Country (2020-2025)
5.2 Americas Aminoglycosides Antibiotics Sales by Type (2020-2025)
5.3 Americas Aminoglycosides Antibiotics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Aminoglycosides Antibiotics Sales by Region
6.1.1 APAC Aminoglycosides Antibiotics Sales by Region (2020-2025)
6.1.2 APAC Aminoglycosides Antibiotics Revenue by Region (2020-2025)
6.2 APAC Aminoglycosides Antibiotics Sales by Type (2020-2025)
6.3 APAC Aminoglycosides Antibiotics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Aminoglycosides Antibiotics by Country
7.1.1 Europe Aminoglycosides Antibiotics Sales by Country (2020-2025)
7.1.2 Europe Aminoglycosides Antibiotics Revenue by Country (2020-2025)
7.2 Europe Aminoglycosides Antibiotics Sales by Type (2020-2025)
7.3 Europe Aminoglycosides Antibiotics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Aminoglycosides Antibiotics by Country
8.1.1 Middle East & Africa Aminoglycosides Antibiotics Sales by Country (2020-2025)
8.1.2 Middle East & Africa Aminoglycosides Antibiotics Revenue by Country (2020-2025)
8.2 Middle East & Africa Aminoglycosides Antibiotics Sales by Type (2020-2025)
8.3 Middle East & Africa Aminoglycosides Antibiotics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Aminoglycosides Antibiotics
10.3 Manufacturing Process Analysis of Aminoglycosides Antibiotics
10.4 Industry Chain Structure of Aminoglycosides Antibiotics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Aminoglycosides Antibiotics Distributors
11.3 Aminoglycosides Antibiotics Customer
12 WORLD FORECAST REVIEW FOR AMINOGLYCOSIDES ANTIBIOTICS BY GEOGRAPHIC REGION
12.1 Global Aminoglycosides Antibiotics Market Size Forecast by Region
12.1.1 Global Aminoglycosides Antibiotics Forecast by Region (2026-2031)
12.1.2 Global Aminoglycosides Antibiotics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Aminoglycosides Antibiotics Forecast by Type (2026-2031)
12.7 Global Aminoglycosides Antibiotics Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Jemicare
13.1.1 Jemicare Company Information
13.1.2 Jemicare Aminoglycosides Antibiotics Product Portfolios and Specifications
13.1.3 Jemicare Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Jemicare Main Business Overview
13.1.5 Jemicare Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Aminoglycosides Antibiotics Product Portfolios and Specifications
13.2.3 Teva Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Aminoglycosides Antibiotics Product Portfolios and Specifications
13.3.3 Novartis Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Fangyuan-pharma
13.4.1 Fangyuan-pharma Company Information
13.4.2 Fangyuan-pharma Aminoglycosides Antibiotics Product Portfolios and Specifications
13.4.3 Fangyuan-pharma Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Fangyuan-pharma Main Business Overview
13.4.5 Fangyuan-pharma Latest Developments
13.5 Aike Pharmaceutical
13.5.1 Aike Pharmaceutical Company Information
13.5.2 Aike Pharmaceutical Aminoglycosides Antibiotics Product Portfolios and Specifications
13.5.3 Aike Pharmaceutical Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Aike Pharmaceutical Main Business Overview
13.5.5 Aike Pharmaceutical Latest Developments
13.6 Cipla
13.6.1 Cipla Company Information
13.6.2 Cipla Aminoglycosides Antibiotics Product Portfolios and Specifications
13.6.3 Cipla Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Cipla Main Business Overview
13.6.5 Cipla Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Aminoglycosides Antibiotics Product Portfolios and Specifications
13.7.3 Pfizer Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Fresenius Kabi
13.8.1 Fresenius Kabi Company Information
13.8.2 Fresenius Kabi Aminoglycosides Antibiotics Product Portfolios and Specifications
13.8.3 Fresenius Kabi Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Fresenius Kabi Main Business Overview
13.8.5 Fresenius Kabi Latest Developments
13.9 Sun Pharma
13.9.1 Sun Pharma Company Information
13.9.2 Sun Pharma Aminoglycosides Antibiotics Product Portfolios and Specifications
13.9.3 Sun Pharma Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Sun Pharma Main Business Overview
13.9.5 Sun Pharma Latest Developments
13.10 Hikma
13.10.1 Hikma Company Information
13.10.2 Hikma Aminoglycosides Antibiotics Product Portfolios and Specifications
13.10.3 Hikma Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Hikma Main Business Overview
13.10.5 Hikma Latest Developments
13.11 Lannett Company
13.11.1 Lannett Company Company Information
13.11.2 Lannett Company Aminoglycosides Antibiotics Product Portfolios and Specifications
13.11.3 Lannett Company Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Lannett Company Main Business Overview
13.11.5 Lannett Company Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Aminoglycosides Antibiotics Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Aminoglycosides Antibiotics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTobramycin
Table 4. Major Players of Gentamicin
Table 5. Major Players of Amikacin
Table 6. Major Players of Etimicin
Table 7. Major Players of Others
Table 8. Global Aminoglycosides Antibiotics Sales byType (2020-2025) & (M Units)
Table 9. Global Aminoglycosides Antibiotics Sales Market Share byType (2020-2025)
Table 10. Global Aminoglycosides Antibiotics Revenue byType (2020-2025) & ($ million)
Table 11. Global Aminoglycosides Antibiotics Revenue Market Share byType (2020-2025)
Table 12. Global Aminoglycosides Antibiotics Sale Price byType (2020-2025) & (US$/Unit)
Table 13. Global Aminoglycosides Antibiotics Sale by Application (2020-2025) & (M Units)
Table 14. Global Aminoglycosides Antibiotics Sale Market Share by Application (2020-2025)
Table 15. Global Aminoglycosides Antibiotics Revenue by Application (2020-2025) & ($ million)
Table 16. Global Aminoglycosides Antibiotics Revenue Market Share by Application (2020-2025)
Table 17. Global Aminoglycosides Antibiotics Sale Price by Application (2020-2025) & (US$/Unit)
Table 18. Global Aminoglycosides Antibiotics Sales by Company (2020-2025) & (M Units)
Table 19. Global Aminoglycosides Antibiotics Sales Market Share by Company (2020-2025)
Table 20. Global Aminoglycosides Antibiotics Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Aminoglycosides Antibiotics Revenue Market Share by Company (2020-2025)
Table 22. Global Aminoglycosides Antibiotics Sale Price by Company (2020-2025) & (US$/Unit)
Table 23. Key Manufacturers Aminoglycosides Antibiotics Producing Area Distribution and Sales Area
Table 24. Players Aminoglycosides Antibiotics Products Offered
Table 25. Aminoglycosides Antibiotics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Aminoglycosides Antibiotics Sales by Geographic Region (2020-2025) & (M Units)
Table 29. Global Aminoglycosides Antibiotics Sales Market Share Geographic Region (2020-2025)
Table 30. Global Aminoglycosides Antibiotics Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Aminoglycosides Antibiotics Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Aminoglycosides Antibiotics Sales by Country/Region (2020-2025) & (M Units)
Table 33. Global Aminoglycosides Antibiotics Sales Market Share by Country/Region (2020-2025)
Table 34. Global Aminoglycosides Antibiotics Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Aminoglycosides Antibiotics Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Aminoglycosides Antibiotics Sales by Country (2020-2025) & (M Units)
Table 37. Americas Aminoglycosides Antibiotics Sales Market Share by Country (2020-2025)
Table 38. Americas Aminoglycosides Antibiotics Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Aminoglycosides Antibiotics Sales byType (2020-2025) & (M Units)
Table 40. Americas Aminoglycosides Antibiotics Sales by Application (2020-2025) & (M Units)
Table 41. APAC Aminoglycosides Antibiotics Sales by Region (2020-2025) & (M Units)
Table 42. APAC Aminoglycosides Antibiotics Sales Market Share by Region (2020-2025)
Table 43. APAC Aminoglycosides Antibiotics Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Aminoglycosides Antibiotics Sales byType (2020-2025) & (M Units)
Table 45. APAC Aminoglycosides Antibiotics Sales by Application (2020-2025) & (M Units)
Table 46. Europe Aminoglycosides Antibiotics Sales by Country (2020-2025) & (M Units)
Table 47. Europe Aminoglycosides Antibiotics Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Aminoglycosides Antibiotics Sales byType (2020-2025) & (M Units)
Table 49. Europe Aminoglycosides Antibiotics Sales by Application (2020-2025) & (M Units)
Table 50. Middle East & Africa Aminoglycosides Antibiotics Sales by Country (2020-2025) & (M Units)
Table 51. Middle East & Africa Aminoglycosides Antibiotics Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Aminoglycosides Antibiotics Sales byType (2020-2025) & (M Units)
Table 53. Middle East & Africa Aminoglycosides Antibiotics Sales by Application (2020-2025) & (M Units)
Table 54. Key Market Drivers & Growth Opportunities of Aminoglycosides Antibiotics
Table 55. Key Market Challenges & Risks of Aminoglycosides Antibiotics
Table 56. Key IndustryTrends of Aminoglycosides Antibiotics
Table 57. Aminoglycosides Antibiotics Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Aminoglycosides Antibiotics Distributors List
Table 60. Aminoglycosides Antibiotics Customer List
Table 61. Global Aminoglycosides Antibiotics SalesForecast by Region (2026-2031) & (M Units)
Table 62. Global Aminoglycosides Antibiotics RevenueForecast by Region (2026-2031) & ($ millions)
Table 63. Americas Aminoglycosides Antibiotics SalesForecast by Country (2026-2031) & (M Units)
Table 64. Americas Aminoglycosides Antibiotics Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 65. APAC Aminoglycosides Antibiotics SalesForecast by Region (2026-2031) & (M Units)
Table 66. APAC Aminoglycosides Antibiotics Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 67. Europe Aminoglycosides Antibiotics SalesForecast by Country (2026-2031) & (M Units)
Table 68. Europe Aminoglycosides Antibiotics RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Aminoglycosides Antibiotics SalesForecast by Country (2026-2031) & (M Units)
Table 70. Middle East & Africa Aminoglycosides Antibiotics RevenueForecast by Country (2026-2031) & ($ millions)
Table 71. Global Aminoglycosides Antibiotics SalesForecast byType (2026-2031) & (M Units)
Table 72. Global Aminoglycosides Antibiotics RevenueForecast byType (2026-2031) & ($ millions)
Table 73. Global Aminoglycosides Antibiotics SalesForecast by Application (2026-2031) & (M Units)
Table 74. Global Aminoglycosides Antibiotics RevenueForecast by Application (2026-2031) & ($ millions)
Table 75. Jemicare Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 76. Jemicare Aminoglycosides Antibiotics Product Portfolios and Specifications
Table 77. Jemicare Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Jemicare Main Business
Table 79. Jemicare Latest Developments
Table 80.Teva Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 81.Teva Aminoglycosides Antibiotics Product Portfolios and Specifications
Table 82.Teva Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83.Teva Main Business
Table 84.Teva Latest Developments
Table 85. Novartis Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 86. Novartis Aminoglycosides Antibiotics Product Portfolios and Specifications
Table 87. Novartis Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Novartis Main Business
Table 89. Novartis Latest Developments
Table 90.Fangyuan-pharma Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 91.Fangyuan-pharma Aminoglycosides Antibiotics Product Portfolios and Specifications
Table 92.Fangyuan-pharma Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93.Fangyuan-pharma Main Business
Table 94.Fangyuan-pharma Latest Developments
Table 95. Aike Pharmaceutical Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 96. Aike Pharmaceutical Aminoglycosides Antibiotics Product Portfolios and Specifications
Table 97. Aike Pharmaceutical Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Aike Pharmaceutical Main Business
Table 99. Aike Pharmaceutical Latest Developments
Table 100. Cipla Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 101. Cipla Aminoglycosides Antibiotics Product Portfolios and Specifications
Table 102. Cipla Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Cipla Main Business
Table 104. Cipla Latest Developments
Table 105. Pfizer Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 106. Pfizer Aminoglycosides Antibiotics Product Portfolios and Specifications
Table 107. Pfizer Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Pfizer Main Business
Table 109. Pfizer Latest Developments
Table 110.Fresenius Kabi Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 111.Fresenius Kabi Aminoglycosides Antibiotics Product Portfolios and Specifications
Table 112.Fresenius Kabi Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113.Fresenius Kabi Main Business
Table 114.Fresenius Kabi Latest Developments
Table 115. Sun Pharma Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 116. Sun Pharma Aminoglycosides Antibiotics Product Portfolios and Specifications
Table 117. Sun Pharma Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Sun Pharma Main Business
Table 119. Sun Pharma Latest Developments
Table 120. Hikma Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 121. Hikma Aminoglycosides Antibiotics Product Portfolios and Specifications
Table 122. Hikma Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Hikma Main Business
Table 124. Hikma Latest Developments
Table 125. Lannett Company Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 126. Lannett Company Aminoglycosides Antibiotics Product Portfolios and Specifications
Table 127. Lannett Company Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Lannett Company Main Business
Table 129. Lannett Company Latest Developments
LIST OFFIGURES
Figure 1. Picture of Aminoglycosides Antibiotics
Figure 2. Aminoglycosides Antibiotics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Aminoglycosides Antibiotics Sales Growth Rate 2020-2031 (M Units)
Figure 7. Global Aminoglycosides Antibiotics Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Aminoglycosides Antibiotics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Aminoglycosides Antibiotics Sales Market Share by Country/Region (2024)
Figure 10. Aminoglycosides Antibiotics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofTobramycin
Figure 12. Product Picture of Gentamicin
Figure 13. Product Picture of Amikacin
Figure 14. Product Picture of Etimicin
Figure 15. Product Picture of Others
Figure 16. Global Aminoglycosides Antibiotics Sales Market Share byType in 2025
Figure 17. Global Aminoglycosides Antibiotics Revenue Market Share byType (2020-2025)
Figure 18. Aminoglycosides Antibiotics Consumed in Hospital
Figure 19. Global Aminoglycosides Antibiotics Market: Hospital (2020-2025) & (M Units)
Figure 20. Aminoglycosides Antibiotics Consumed in Clinic
Figure 21. Global Aminoglycosides Antibiotics Market: Clinic (2020-2025) & (M Units)
Figure 22. Aminoglycosides Antibiotics Consumed in Others
Figure 23. Global Aminoglycosides Antibiotics Market: Others (2020-2025) & (M Units)
Figure 24. Global Aminoglycosides Antibiotics Sale Market Share by Application (2024)
Figure 25. Global Aminoglycosides Antibiotics Revenue Market Share by Application in 2025
Figure 26. Aminoglycosides Antibiotics Sales by Company in 2025 (M Units)
Figure 27. Global Aminoglycosides Antibiotics Sales Market Share by Company in 2025
Figure 28. Aminoglycosides Antibiotics Revenue by Company in 2025 ($ millions)
Figure 29. Global Aminoglycosides Antibiotics Revenue Market Share by Company in 2025
Figure 30. Global Aminoglycosides Antibiotics Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Aminoglycosides Antibiotics Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Aminoglycosides Antibiotics Sales 2020-2025 (M Units)
Figure 33. Americas Aminoglycosides Antibiotics Revenue 2020-2025 ($ millions)
Figure 34. APAC Aminoglycosides Antibiotics Sales 2020-2025 (M Units)
Figure 35. APAC Aminoglycosides Antibiotics Revenue 2020-2025 ($ millions)
Figure 36. Europe Aminoglycosides Antibiotics Sales 2020-2025 (M Units)
Figure 37. Europe Aminoglycosides Antibiotics Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Aminoglycosides Antibiotics Sales 2020-2025 (M Units)
Figure 39. Middle East & Africa Aminoglycosides Antibiotics Revenue 2020-2025 ($ millions)
Figure 40. Americas Aminoglycosides Antibiotics Sales Market Share by Country in 2025
Figure 41. Americas Aminoglycosides Antibiotics Revenue Market Share by Country (2020-2025)
Figure 42. Americas Aminoglycosides Antibiotics Sales Market Share byType (2020-2025)
Figure 43. Americas Aminoglycosides Antibiotics Sales Market Share by Application (2020-2025)
Figure 44. United States Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Aminoglycosides Antibiotics Sales Market Share by Region in 2025
Figure 49. APAC Aminoglycosides Antibiotics Revenue Market Share by Region (2020-2025)
Figure 50. APAC Aminoglycosides Antibiotics Sales Market Share byType (2020-2025)
Figure 51. APAC Aminoglycosides Antibiotics Sales Market Share by Application (2020-2025)
Figure 52. China Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 56. India Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 58. ChinaTaiwan Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Aminoglycosides Antibiotics Sales Market Share by Country in 2025
Figure 60. Europe Aminoglycosides Antibiotics Revenue Market Share by Country (2020-2025)
Figure 61. Europe Aminoglycosides Antibiotics Sales Market Share byType (2020-2025)
Figure 62. Europe Aminoglycosides Antibiotics Sales Market Share by Application (2020-2025)
Figure 63. Germany Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 64.France Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Aminoglycosides Antibiotics Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Aminoglycosides Antibiotics Sales Market Share byType (2020-2025)
Figure 70. Middle East & Africa Aminoglycosides Antibiotics Sales Market Share by Application (2020-2025)
Figure 71. Egypt Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 74.Turkey Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Aminoglycosides Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Aminoglycosides Antibiotics in 2025
Figure 77. Manufacturing Process Analysis of Aminoglycosides Antibiotics
Figure 78. Industry Chain Structure of Aminoglycosides Antibiotics
Figure 79. Channels of Distribution
Figure 80. Global Aminoglycosides Antibiotics Sales MarketForecast by Region (2026-2031)
Figure 81. Global Aminoglycosides Antibiotics Revenue Market ShareForecast by Region (2026-2031)
Figure 82. Global Aminoglycosides Antibiotics Sales Market ShareForecast byType (2026-2031)
Figure 83. Global Aminoglycosides Antibiotics Revenue Market ShareForecast byType (2026-2031)
Figure 84. Global Aminoglycosides Antibiotics Sales Market ShareForecast by Application (2026-2031)
Figure 85. Global Aminoglycosides Antibiotics Revenue Market ShareForecast by Application (2026-2031)
